Clinical Trial Update: Study of Genetic Factors Other Than CYP2C9 and VKORC1 That Influence Warfarin Dose Requirements in a South-east Asian Population

View source ↗

Summary

A study investigates genetic factors influencing warfarin dose beyond CYP2C9 and VKORC1 in a Southeast Asian population, focusing on cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Cancer | Status: UNKNOWN